AFATINIB

AFATINIB was reported 6622 times

AFATINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HER2 MUTANT NON-SMALL CELL LUNG CANCER 3 0.2727
1 EGFR GENE MUTATION 88 0.2353
2 ADENOSQUAMOUS CELL CARCINOMA 3 0.1667
3 TYROSINE KINASE MUTATION 3 0.1200
4 MALIGNANT NEOPLASM OF PLEURA 10 0.0813
5 PARONYCHIA 355 0.0807
6 VITH NERVE PARESIS 4 0.0645
7 NAIL CUTICLE FISSURE 4 0.0606
8 CHORDOMA 6 0.0583
9 NAIL BED INFECTION 11 0.0462
10 DRUG RESISTANCE MUTATION 8 0.0449
11 NASAL MUCOSAL ULCER 3 0.0361
12 METASTASES TO MENINGES 81 0.0356
13 MUCOCUTANEOUS RASH 5 0.0325
14 SMALL CELL CARCINOMA 11 0.0320
15 ACQUIRED GENE MUTATION 38 0.0290
16 NAIL BED INFLAMMATION 9 0.0282
17 MALIGNANT GLIOMA 4 0.0282
18 FEMORAL HERNIA INCARCERATED 2 0.0278
19 LYMPHANGIOSIS CARCINOMATOSA 27 0.0259
20 MUCOCUTANEOUS DISORDER 4 0.0252
21 DERMATITIS ACNEIFORM 152 0.0250
22 BLOOD LACTATE DEHYDROGENASE 2 0.0247
23 METASTASES TO EYE 5 0.0228
24 XERODERMA 6 0.0225
25 MALIGNANT FIBROUS HISTIOCYTOMA 3 0.0222
26 GENE MUTATION 44 0.0222
27 SMALL CELL LUNG CANCER 33 0.0218
28 METASTASES TO CENTRAL NERVOUS SYSTEM 270 0.0209
29 METASTASES TO SPINAL CORD 4 0.0206
30 CUTANEOUS SYMPTOM 14 0.0205
31 NAIL INFECTION 29 0.0202
32 MALIGNANT TRANSFORMATION 9 0.0200
33 GASTROENTERITIS STAPHYLOCOCCAL 3 0.0191
34 HANGNAIL 3 0.0173
35 PERICARDIAL EFFUSION MALIGNANT 3 0.0169
36 EYELASH THICKENING 2 0.0167
37 MALIGNANT NEOPLASM PROGRESSION 1696 0.0165
38 ANGULAR CHEILITIS 11 0.0159
39 BLOOD ALBUMIN ABNORMAL 8 0.0154
40 METASTASES TO ADRENALS 14 0.0152
41 MALIGNANT NEOPLASM OLIGOPROGRESSION 3 0.0151
42 COUGH DECREASED 2 0.0150
43 RADIATION NECROSIS 8 0.0140
44 NON-SMALL CELL LUNG CANCER 66 0.0138
45 BASOSQUAMOUS CARCINOMA 2 0.0134
46 NAIL TOXICITY 4 0.0133
47 CONJUNCTIVAL DISORDER 5 0.0131
48 SKIN TOXICITY 74 0.0131
49 MUCOSAL INFECTION 3 0.0128
50 CANCER IN REMISSION 3 0.0124
51 CHEST WALL MASS 3 0.0115
52 METASTASES TO PLEURA 12 0.0114
53 NON-SMALL CELL LUNG CANCER METASTATIC 10 0.0114
54 GROWTH OF EYELASHES 9 0.0114
55 LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT 7 0.0113
56 THORACIC CAVITY DRAINAGE 3 0.0112
57 MUCOSAL TOXICITY 3 0.0111
58 LUNG ADENOCARCINOMA 33 0.0110
59 NAIL BED BLEEDING 6 0.0105
60 LUNG ADENOCARCINOMA STAGE IV 4 0.0105
61 BURN ORAL CAVITY 6 0.0104
62 BRAIN CANCER METASTATIC 7 0.0101
63 ONYCHALGIA 10 0.0100
64 ORTHOPAEDIC PROCEDURE 5 0.0097
65 ADRENOMEGALY 2 0.0096
66 NAIL DISORDER 84 0.0096
67 MALIGNANT PLEURAL EFFUSION 16 0.0095
68 EYELASH DISCOLOURATION 2 0.0091
69 HYPERPLASIA 8 0.0089
70 ONYCHOCLASIS 59 0.0086
71 NASAL INFLAMMATION 9 0.0085
72 PRERENAL FAILURE 12 0.0085
73 SMALL CELL LUNG CANCER METASTATIC 3 0.0085
74 ELECTROLYTE DEPLETION 4 0.0081
75 XEROSIS 10 0.0081
76 STOMATITIS 486 0.0080
77 LYMPHADENOPATHY MEDIASTINAL 15 0.0078
78 SKIN ULCER HAEMORRHAGE 3 0.0078
79 CARCINOEMBRYONIC ANTIGEN INCREASED 15 0.0077
80 CRANIOTOMY 3 0.0073
81 TONGUE ERYTHEMA 6 0.0073
82 GENE MUTATION IDENTIFICATION TEST POSITIVE 3 0.0071
83 CARBUNCLE 2 0.0071
84 NAIL BED DISORDER 3 0.0070
85 NASAL INJURY 5 0.0069
86 EYE INFECTION STAPHYLOCOCCAL 2 0.0069
87 NASAL MUCOSAL DISORDER 4 0.0069
88 DUODENAL OBSTRUCTION 2 0.0067
89 SUPERIOR VENA CAVA SYNDROME 4 0.0066
90 METASTASES TO SPINE 22 0.0065
91 CORNEAL LESION 2 0.0065
92 RASH PUSTULAR 47 0.0064
93 BRONCHIAL CARCINOMA 5 0.0063
94 METASTASES TO PELVIS 4 0.0063
95 METASTASES TO ABDOMINAL CAVITY 3 0.0061
96 ACNE PUSTULAR 5 0.0061
97 AMYLASE INCREASED 22 0.0060
98 INGROWING NAIL 14 0.0059
99 METASTATIC SQUAMOUS CELL CARCINOMA 3 0.0059
100 NASAL ULCER 9 0.0056
101 DRUG RESISTANCE 142 0.0055
102 METASTASES TO BONE 90 0.0055
103 GASTROINTESTINAL TOXICITY 26 0.0054
104 ADENOCARCINOMA 12 0.0053
105 NAIL INJURY 3 0.0053
106 LIP PAIN 15 0.0052
107 SQUAMOUS CELL CARCINOMA OF LUNG 4 0.0052
108 THERAPY PARTIAL RESPONDER 80 0.0051
109 EFFUSION 7 0.0051
110 XEROPHTHALMIA 3 0.0051
111 CANCER PAIN 13 0.0051
112 DROWNING 5 0.0049
113 METASTASES TO LUNG 57 0.0049
114 METASTASIS 35 0.0049
115 BILIARY TRACT INFECTION 3 0.0048
116 CHLOROMA 2 0.0047
117 NASAL CRUSTING 3 0.0046
118 CHEILITIS 25 0.0046
119 PNEUMATOSIS INTESTINALIS 13 0.0046
120 NAIL GROWTH ABNORMAL 5 0.0045
121 MUCOSAL INFLAMMATION 118 0.0045
122 NASAL DRYNESS 28 0.0045
123 PARANEOPLASTIC SYNDROME 3 0.0044
124 PNEUMOTHORAX SPONTANEOUS 3 0.0044
125 METASTASES TO LIVER 77 0.0044
126 EPIDERMOLYSIS 2 0.0043
127 NEUROENDOCRINE CARCINOMA 3 0.0043
128 POSITRON EMISSION TOMOGRAM ABNORMAL 3 0.0043
129 SEBORRHOEIC DERMATITIS 7 0.0042
130 GLOSSITIS 15 0.0042
131 DERMATITIS INFECTED 2 0.0040
132 MALIGNANT ASCITES 3 0.0039
133 CREATINE KINASE INCREASED 3 0.0039
134 SKIN SENSITISATION 4 0.0039
135 ACUTE INTERSTITIAL PNEUMONITIS 2 0.0038
136 LIP ERYTHEMA 3 0.0038
137 CHAPPED LIPS 16 0.0037
138 RENAL ABSCESS 3 0.0037
139 MUCOUS MEMBRANE DISORDER 5 0.0037
140 SKIN FISSURES 71 0.0036
141 KERATITIS 11 0.0036
142 METASTASES TO PERITONEUM 9 0.0036
143 EMPYEMA 7 0.0035
144 ORAL PAIN 78 0.0035
145 HILAR LYMPHADENOPATHY 3 0.0034
146 NASAL DISCOMFORT 27 0.0034
147 EYE BURNS 2 0.0034
148 LIP BLISTER 9 0.0033
149 DIARRHOEA 2128 0.0033
150 METASTASES TO LYMPH NODES 22 0.0033
151 BIOPSY 3 0.0032
152 ORAL MUCOSAL ERYTHEMA 5 0.0032
153 NEUTROPHIL COUNT ABNORMAL 9 0.0032
154 LIP HAEMORRHAGE 4 0.0031
155 LUNG CANCER METASTATIC 9 0.0031
156 INTERSTITIAL LUNG DISEASE 150 0.0031
157 PNEUMONITIS 84 0.0031
158 DUODENAL PERFORATION 3 0.0031
159 TUMOUR PAIN 4 0.0030
160 EMBOLIC CEREBRAL INFARCTION 2 0.0030
161 PLEURAL EFFUSION 181 0.0030
162 APHTHOUS ULCER 23 0.0030
163 METASTASES TO SKIN 3 0.0029
164 MULTIPLE-DRUG RESISTANCE 9 0.0029
165 HAIR GROWTH ABNORMAL 20 0.0029
166 ONYCHOMADESIS 12 0.0029
167 OESOPHAGEAL STENOSIS 8 0.0028
168 RADIATION PNEUMONITIS 6 0.0028
169 TUMOUR HAEMORRHAGE 8 0.0028
170 DIET REFUSAL 2 0.0027
171 SARCOMA 3 0.0027
172 SKIN DISORDER 88 0.0026
173 INFECTIOUS PLEURAL EFFUSION 4 0.0026
174 ORAL MUCOSAL ERUPTION 4 0.0026
175 ASPIRATION PLEURAL CAVITY 2 0.0026
176 CYTOMEGALOVIRUS ENTEROCOLITIS 2 0.0026
177 EARLY SATIETY 5 0.0026
178 CRITICAL ILLNESS 2 0.0026
179 MEGACOLON 4 0.0025
180 ONYCHOMYCOSIS 11 0.0025
181 MUCOSAL DRYNESS 5 0.0025
182 RECURRENT CANCER 10 0.0024
183 ANAL ULCER 2 0.0024
184 IMMUNE-MEDIATED ENTEROCOLITIS 9 0.0024
185 DUODENAL ULCER HAEMORRHAGE 7 0.0024
186 ENTEROCOLITIS 14 0.0024
187 PULMONARY MASS 36 0.0024
188 ADRENAL MASS 2 0.0024
189 DEHYDRATION 317 0.0024
190 PERFORMANCE STATUS DECREASED 11 0.0024
191 ABNORMAL LOSS OF WEIGHT 16 0.0023
192 MOUTH ULCERATION 49 0.0023
193 ELECTROLYTE IMBALANCE 27 0.0023
194 ENTEROVIRUS INFECTION 2 0.0023
195 ABDOMINAL LYMPHADENOPATHY 2 0.0023
196 LIP INJURY 3 0.0023
197 OBLITERATIVE BRONCHIOLITIS 3 0.0023
198 PHARYNGEAL ULCERATION 3 0.0023
199 BLOOD ALKALINE PHOSPHATASE ABNORMAL 2 0.0022
200 ACNE 168 0.0022
201 SIALOADENITIS 3 0.0022
202 EYELID DISORDER 5 0.0022
203 ALVEOLITIS 3 0.0021
204 BLOOD ELECTROLYTES DECREASED 3 0.0021
205 LUNG NEOPLASM 9 0.0021
206 CARDIAC TAMPONADE 10 0.0021
207 GENITAL RASH 3 0.0021
208 SINUS OPERATION 5 0.0021
209 METASTATIC NEOPLASM 9 0.0021
210 BLOOD URINE 2 0.0021
211 PULMONARY PAIN 6 0.0021
212 CENTRAL NERVOUS SYSTEM LESION 28 0.0020
213 RASH 884 0.0020
214 CARDIAC ANEURYSM 2 0.0020
215 BRAIN NEOPLASM MALIGNANT 9 0.0020
216 NEOPLASM PROGRESSION 70 0.0020
217 GASTROINTESTINAL TUBE INSERTION 5 0.0020
218 MOUTH INJURY 3 0.0020
219 ASPARTATE AMINOTRANSFERASE ABNORMAL 3 0.0020
220 CACHEXIA 10 0.0019
221 DECREASED APPETITE 450 0.0019
222 GASTROINTESTINAL PERFORATION 8 0.0019
223 SUBILEUS 4 0.0019
224 NEOPLASM 22 0.0019
225 TONGUE DISCOMFORT 8 0.0019
226 GASTROINTESTINAL STROMAL TUMOUR 5 0.0019
227 EPISTAXIS 139 0.0019
228 HEPATIC LESION 8 0.0018
229 HAIR DISORDER 15 0.0018
230 GASTRIC ULCER HAEMORRHAGE 10 0.0018
231 TONGUE BLISTERING 4 0.0018
232 TRICHORRHEXIS 5 0.0018
233 ILEUS PARALYTIC 8 0.0018
234 FEEDING DISORDER 36 0.0018
235 DISEASE PROGRESSION 209 0.0018
236 COMPUTERISED TOMOGRAM ABNORMAL 4 0.0018
237 ENTERITIS INFECTIOUS 3 0.0018
238 BLOODY DISCHARGE 2 0.0017
239 ESCHERICHIA SEPSIS 5 0.0017
240 HAEMOTHORAX 5 0.0017
241 SKIN REACTION 24 0.0017
242 GLOSSODYNIA 38 0.0017
243 BONE MARROW TOXICITY 2 0.0017
244 PUSTULE 4 0.0017
245 VOCAL CORD PARALYSIS 3 0.0017
246 SCAB 19 0.0017
247 BONE LESION 6 0.0017
248 PIGMENTATION DISORDER 10 0.0016
249 LEUKOENCEPHALOPATHY 6 0.0016
250 HYPOPROTEINAEMIA 3 0.0016
251 PNEUMOTHORAX 25 0.0016
252 HEPATITIS B REACTIVATION 5 0.0016
253 DERMATITIS 33 0.0016
254 BLOOD BILIRUBIN ABNORMAL 2 0.0016
255 TRAUMATIC LUNG INJURY 3 0.0016
256 LIP DRY 14 0.0015
257 ILEUS 19 0.0015
258 FOLLICULITIS 16 0.0015
259 LUNG OPACITY 4 0.0015
260 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 35 0.0015
261 ORAL DISORDER 11 0.0015
262 HAIR TEXTURE ABNORMAL 20 0.0015
263 DRY SKIN 199 0.0015
264 NEOPLASM RECURRENCE 5 0.0015
265 IMMUNE-MEDIATED HEPATITIS 3 0.0015
266 OSTEOLYSIS 3 0.0015
267 ULCERATIVE KERATITIS 4 0.0015
268 EATING DISORDER 31 0.0015
269 RHINALGIA 4 0.0015
270 CONJUNCTIVITIS 27 0.0015
271 BILIARY TRACT DISORDER 2 0.0014
272 HYPERTRANSAMINASAEMIA 10 0.0014
273 LUNG CONSOLIDATION 4 0.0014
274 PROCTITIS 4 0.0014
275 ALANINE AMINOTRANSFERASE ABNORMAL 3 0.0014
276 MOUTH SWELLING 8 0.0014
277 EYELID MARGIN CRUSTING 4 0.0014
278 TONGUE DISCOLOURATION 6 0.0014
279 CORNEAL DISORDER 3 0.0014
280 MOUTH HAEMORRHAGE 10 0.0014
281 LUNG INFECTION 21 0.0014
282 MENINGITIS 9 0.0013
283 BRAIN OEDEMA 17 0.0013
284 HYPOKALAEMIA 62 0.0013
285 LARGE INTESTINAL OBSTRUCTION 3 0.0013
286 PERICARDIAL EFFUSION 31 0.0013
287 ODYNOPHAGIA 8 0.0013
288 ATYPICAL PNEUMONIA 4 0.0013
289 HAEMOPTYSIS 37 0.0013
290 BRAIN NEOPLASM 12 0.0013
291 DRUG ERUPTION 23 0.0013
292 SPINAL CORD COMPRESSION 5 0.0013
293 SKIN ULCER 33 0.0013
294 BLOOD MAGNESIUM DECREASED 11 0.0013
295 PULMONARY TOXICITY 9 0.0013
296 NAIL DISCOLOURATION 5 0.0013
297 RASH MACULO-PAPULAR 28 0.0013
298 INTRACRANIAL PRESSURE INCREASED 7 0.0013
299 TUMOUR MARKER INCREASED 6 0.0012
300 SKIN INFECTION 14 0.0012
301 LUNG INFILTRATION 11 0.0012
302 VULVOVAGINAL DRYNESS 4 0.0012
303 HEPATIC NEOPLASM 4 0.0012
304 CEREBRAL DISORDER 9 0.0012
305 HYPERURICAEMIA 5 0.0012
306 SKIN ATROPHY 7 0.0012
307 ORGANISING PNEUMONIA 6 0.0012
308 SKIN INJURY 4 0.0012
309 BRAIN INJURY 12 0.0012
310 TONGUE ULCERATION 4 0.0012
311 GASTROENTERITIS 17 0.0012
312 HEPATITIS TOXIC 3 0.0012
313 MONOPLEGIA 5 0.0011
314 THROMBOTIC THROMBOCYTOPENIC PURPURA 4 0.0011
315 BLOOD POTASSIUM DECREASED 34 0.0011
316 LUNG NEOPLASM MALIGNANT 46 0.0011
317 BLOOD CREATININE INCREASED 73 0.0011
318 GINGIVITIS 6 0.0011
319 OESOPHAGITIS 12 0.0011
320 FOOD INTOLERANCE 4 0.0011
321 LUNG DISORDER 53 0.0011
322 LIP SWELLING 36 0.0011
323 DYSENTERY 2 0.0011
324 EYE DISCHARGE 11 0.0011
325 BILE DUCT OBSTRUCTION 2 0.0011
326 RETINAL VEIN OCCLUSION 3 0.0010
327 STRESS CARDIOMYOPATHY 6 0.0010
328 HYPOALBUMINAEMIA 8 0.0010
329 HAEMORRHOIDAL HAEMORRHAGE 5 0.0010
330 DRY MOUTH 83 0.0010
331 HYPOPHAGIA 26 0.0010
332 RESPIRATORY FAILURE 74 0.0010
333 AUTOIMMUNE HEPATITIS 7 0.0010
334 AZOTAEMIA 4 0.0010
335 DUODENAL ULCER 7 0.0010
336 LYMPHOPENIA 14 0.0010
337 DRUG TOLERANCE 5 0.0010
338 EAR HAEMORRHAGE 2 0.0010
339 CEREBRAL INFARCTION 24 0.0010
340 DRY EYE 49 0.0010
341 CHEST X-RAY ABNORMAL 3 0.0010
342 DUODENITIS 3 0.0010
343 CEREBRAL ISCHAEMIA 5 0.0010
344 DYSGEUSIA 72 0.0010
345 HYPERBILIRUBINAEMIA 10 0.0010
346 FAECES SOFT 7 0.0010
347 LACERATION 9 0.0010
348 LOCALISED INFECTION 23 0.0010
349 ULCER 15 0.0009
350 ORAL DISCOMFORT 13 0.0009
351 RHINORRHOEA 60 0.0009
352 ERYTHEMA OF EYELID 5 0.0009
353 HYDROCEPHALUS 5 0.0009
354 CLOSTRIDIUM DIFFICILE INFECTION 20 0.0009
355 SKIN LESION 25 0.0009
356 HYPERKERATOSIS 5 0.0009
357 BLOOD CREATINE INCREASED 4 0.0009
358 INTESTINAL PERFORATION 10 0.0009
359 B-CELL LYMPHOMA 3 0.0009
360 CHOLECYSTITIS ACUTE 5 0.0009
361 REGURGITATION 3 0.0009
362 VOMITING 410 0.0009
363 UROSEPSIS 8 0.0009
364 RENAL FUNCTION TEST ABNORMAL 4 0.0009
365 DECUBITUS ULCER 7 0.0009
366 HYPOVOLAEMIA 5 0.0009
367 SPINAL PAIN 10 0.0009
368 DYSPHAGIA 81 0.0009
369 EMBOLIC STROKE 3 0.0009
370 JAUNDICE CHOLESTATIC 3 0.0008
371 SKIN ABRASION 4 0.0008
372 FIBRIN D DIMER INCREASED 3 0.0008
373 PROTEINURIA 16 0.0008
374 SKIN WEEPING 3 0.0008
375 HYPOVOLAEMIC SHOCK 4 0.0008
376 APPARENT DEATH 3 0.0008
377 TONGUE DISORDER 6 0.0008
378 DERMATITIS BULLOUS 6 0.0008
379 RASH VESICULAR 4 0.0008
380 PULMONARY THROMBOSIS 9 0.0008
381 INCORRECT DOSAGE ADMINISTERED 4 0.0008
382 CHOLANGITIS 5 0.0008
383 SKIN EXFOLIATION 68 0.0008
384 AGEUSIA 20 0.0008
385 GASTRITIS 21 0.0008
386 HEPATIC NECROSIS 3 0.0008
387 ERYSIPELAS 4 0.0008
388 PURPURA 7 0.0008
389 FACE INJURY 3 0.0008
390 PATHOLOGICAL FRACTURE 4 0.0008
391 CONJUNCTIVAL HAEMORRHAGE 3 0.0008
392 LIPASE INCREASED 6 0.0008
393 ABDOMINAL INFECTION 2 0.0008
394 HYPONATRAEMIA 44 0.0008
395 PAIN OF SKIN 21 0.0008
396 STEVENS-JOHNSON SYNDROME 17 0.0008
397 PNEUMONIA BACTERIAL 7 0.0008
398 PNEUMONIA ASPIRATION 19 0.0008
399 FURUNCLE 6 0.0008
400 ERYTHEMA MULTIFORME 7 0.0007
401 DIARRHOEA HAEMORRHAGIC 7 0.0007
402 SKIN MASS 5 0.0007
403 ASCITES 22 0.0007
404 GASTROINTESTINAL MOTILITY DISORDER 4 0.0007
405 ANAL FISSURE 4 0.0007
406 FUNGAL SKIN INFECTION 3 0.0007
407 WEIGHT DECREASED 207 0.0007
408 TASTE DISORDER 15 0.0007
409 GINGIVAL BLEEDING 10 0.0007
410 LACRIMATION INCREASED 22 0.0007
411 INTESTINAL ISCHAEMIA 4 0.0007
412 EMBOLISM 6 0.0007
413 CYSTITIS 23 0.0007
414 CHOLECYSTITIS INFECTIVE 2 0.0007
415 LARGE INTESTINE PERFORATION 5 0.0007
416 TRANSAMINASES INCREASED 16 0.0007
417 ANAL HAEMORRHAGE 2 0.0007
418 DRUG TOLERANCE DECREASED 2 0.0007
419 HYPOXIA 25 0.0007
420 ALOPECIA 139 0.0007
421 ACUTE LYMPHOCYTIC LEUKAEMIA 2 0.0007
422 LYMPHADENOPATHY 25 0.0007
423 NEUTROPENIC SEPSIS 5 0.0007
424 NEUROLOGICAL SYMPTOM 4 0.0007
425 OCULAR ICTERUS 3 0.0007
426 IMMOBILE 3 0.0007
427 GASTRIC ULCER 13 0.0007
428 MELAENA 15 0.0007
429 DRUG EFFECT INCOMPLETE 24 0.0007
430 RASH MACULAR 23 0.0007
431 RASH GENERALISED 17 0.0007
432 DISEASE COMPLICATION 3 0.0007
433 CANDIDA INFECTION 11 0.0007
434 DIASTOLIC DYSFUNCTION 2 0.0006
435 ROSACEA 3 0.0006
436 DRUG INTOLERANCE 62 0.0006
437 DISSEMINATED INTRAVASCULAR COAGULATION 9 0.0006
438 PULMONARY HAEMORRHAGE 5 0.0006
439 BLOOD CREATININE DECREASED 2 0.0006
440 ACUTE KIDNEY INJURY 97 0.0006
441 ASTHENIA 238 0.0006
442 BLOOD ALBUMIN DECREASED 5 0.0006
443 HEPATOTOXICITY 14 0.0006
444 GINGIVAL PAIN 5 0.0006
445 ENTERITIS 4 0.0006
446 NEPHROPATHY TOXIC 7 0.0006
447 VULVOVAGINAL PAIN 3 0.0006
448 PROCTALGIA 4 0.0006
449 EYE INFECTION 7 0.0006
450 ALANINE AMINOTRANSFERASE INCREASED 38 0.0006
451 NAUSEA 488 0.0006
452 DYSPNOEA EXERTIONAL 23 0.0006
453 ABNORMAL FAECES 5 0.0006
454 OEDEMA 33 0.0006
455 BREATH SOUNDS ABNORMAL 3 0.0006
456 DEATH 524 0.0006
457 COLITIS 23 0.0006
458 INFLAMMATORY MARKER INCREASED 3 0.0006
459 SPINAL COMPRESSION FRACTURE 5 0.0006
460 ANAEMIA 115 0.0006
461 HYPERNATRAEMIA 3 0.0006
462 SALIVARY HYPERSECRETION 6 0.0006
463 FLUID INTAKE REDUCED 3 0.0006
464 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
465 HEPATIC FAILURE 18 0.0006
466 PNEUMONIA 192 0.0006
467 TOXIC EPIDERMAL NECROLYSIS 9 0.0006
468 VULVOVAGINAL PRURITUS 3 0.0006
469 HYPOCALCAEMIA 11 0.0006
470 RASH PAPULAR 13 0.0006
471 PANCREATITIS ACUTE 13 0.0006
472 SWOLLEN TONGUE 18 0.0006
473 CHROMATURIA 13 0.0006
474 HYPOMAGNESAEMIA 8 0.0006
475 PULMONARY FIBROSIS 11 0.0006
476 APHONIA 8 0.0006
477 RASH PRURITIC 31 0.0006
478 TUMOUR LYSIS SYNDROME 5 0.0006
479 BRONCHIOLITIS 2 0.0006
480 PAPULE 4 0.0006
481 CLOSTRIDIUM DIFFICILE COLITIS 6 0.0006
482 OSTEONECROSIS OF JAW 14 0.0006
483 ASPARTATE AMINOTRANSFERASE INCREASED 30 0.0006
484 HEPATIC FUNCTION ABNORMAL 21 0.0006
485 HAIR COLOUR CHANGES 7 0.0006
486 EPILEPSY 17 0.0006
487 TREATMENT FAILURE 46 0.0006
488 CONSTIPATION 120 0.0005
489 HEPATIC CYTOLYSIS 7 0.0005
490 CARDIAC FAILURE 44 0.0005
491 CUTANEOUS VASCULITIS 2 0.0005
492 PULMONARY EMBOLISM 52 0.0005
493 FLATULENCE 31 0.0005
494 DYSURIA 20 0.0005
495 SENSITIVE SKIN 4 0.0005
496 GAMMA-GLUTAMYLTRANSFERASE INCREASED 12 0.0005
497 LIVER DISORDER 24 0.0005
498 SKIN HAEMORRHAGE 8 0.0005
499 NECROSIS 3 0.0005
500 CARDIAC DYSFUNCTION 2 0.0005
501 MALNUTRITION 6 0.0005
502 OROPHARYNGEAL PAIN 49 0.0005
503 CATHETER SITE INFECTION 2 0.0005
504 SHOCK 12 0.0005
505 BLOOD CREATINE PHOSPHOKINASE INCREASED 15 0.0005
506 HERPES VIRUS INFECTION 3 0.0005
507 MUSCULOSKELETAL CHEST PAIN 8 0.0005
508 LIVER FUNCTION TEST ABNORMAL 15 0.0005
509 CARDIOPULMONARY FAILURE 2 0.0005
510 HAEMATEMESIS 13 0.0005
511 EPIGASTRIC DISCOMFORT 2 0.0005
512 DRUG-INDUCED LIVER INJURY 16 0.0005
513 GENERAL PHYSICAL HEALTH DETERIORATION 59 0.0005
514 ACUTE RESPIRATORY DISTRESS SYNDROME 9 0.0005
515 CHOLECYSTITIS 6 0.0005
516 BLEPHARITIS 2 0.0005
517 BLISTER 28 0.0005
518 PNEUMOCYSTIS JIROVECII PNEUMONIA 5 0.0005
519 HEPATITIS B 3 0.0005
520 ADRENAL INSUFFICIENCY 6 0.0005
521 VULVOVAGINAL BURNING SENSATION 3 0.0005
522 SHOCK HAEMORRHAGIC 4 0.0005
523 HICCUPS 4 0.0005
524 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
525 DRUG LEVEL INCREASED 8 0.0005
526 AORTIC DISSECTION 2 0.0005
527 JAUNDICE 13 0.0005
528 PERITONITIS 10 0.0005
529 SECOND PRIMARY MALIGNANCY 4 0.0005
530 PRE-EXISTING CONDITION IMPROVED 3 0.0005
531 FUNGAL INFECTION 16 0.0005
532 TENDERNESS 5 0.0005
533 PYREXIA 166 0.0005
534 LIMB INJURY 13 0.0005
535 HEMIPARESIS 8 0.0005
536 RENAL DISORDER 22 0.0005
537 AORTIC VALVE INCOMPETENCE 2 0.0005
538 ACUTE RESPIRATORY FAILURE 9 0.0005
539 INCOHERENT 3 0.0005
540 DIPLOPIA 12 0.0005
541 PYELONEPHRITIS 4 0.0005
542 HAEMORRHOIDS 9 0.0005
543 ORAL HERPES 9 0.0005
544 SKIN SWELLING 4 0.0005
545 PRODUCTIVE COUGH 22 0.0005
546 NODULE 6 0.0005
547 PULMONARY CONGESTION 6 0.0005
548 DEVICE RELATED INFECTION 7 0.0005
549 EYE HAEMORRHAGE 6 0.0004
550 FACIAL PAIN 4 0.0004
551 MALIGNANT MELANOMA 6 0.0004
552 PANCYTOPENIA 25 0.0004
553 QUALITY OF LIFE DECREASED 6 0.0004
554 BRONCHIECTASIS 3 0.0004
555 SEPSIS 49 0.0004
556 RENAL FAILURE 58 0.0004
557 BLOOD THYROID STIMULATING HORMONE INCREASED 4 0.0004
558 EYE OPERATION 2 0.0004
559 ENCEPHALITIS 3 0.0004
560 AGRANULOCYTOSIS 8 0.0004
561 PRURITUS 165 0.0004
562 FLANK PAIN 4 0.0004
563 INFLAMMATION 22 0.0004
564 PHOTOPHOBIA 8 0.0004
565 BLOOD SODIUM DECREASED 8 0.0004
566 PULMONARY OEDEMA 19 0.0004
567 THERAPEUTIC RESPONSE UNEXPECTED 19 0.0004
568 OCULAR HYPERAEMIA 20 0.0004
569 BLOOD URINE PRESENT 8 0.0004
570 ABDOMINAL PAIN 98 0.0004
571 URINARY TRACT INFECTION 71 0.0004
572 ALTERED STATE OF CONSCIOUSNESS 9 0.0004
573 FAECES DISCOLOURED 9 0.0004
574 ATELECTASIS 4 0.0004
575 SEPTIC SHOCK 18 0.0004
576 COUGH 115 0.0004
577 EYE PAIN 23 0.0004
578 DYSPEPSIA 40 0.0004
579 HOSPICE CARE 4 0.0004
580 NEOPLASM MALIGNANT 27 0.0004
581 DISORIENTATION 16 0.0004
582 PHARYNGITIS 5 0.0004
583 HYDRONEPHROSIS 3 0.0004
584 EMPHYSEMA 4 0.0004
585 EYE DISORDER 13 0.0004
586 TROPONIN INCREASED 3 0.0004
587 AORTIC ANEURYSM 3 0.0004
588 BONE MARROW FAILURE 8 0.0004
589 DRY THROAT 4 0.0004
590 NEUTROPHIL COUNT DECREASED 16 0.0004
591 MOTOR DYSFUNCTION 4 0.0004
592 HEPATITIS 10 0.0004
593 GASTROINTESTINAL DISORDER 35 0.0004
594 ENDOCARDITIS 2 0.0004
595 BRONCHOPULMONARY ASPERGILLOSIS 3 0.0004
596 EYE PRURITUS 13 0.0004
597 EJECTION FRACTION DECREASED 6 0.0004
598 DYSPNOEA 218 0.0004
599 GASTROINTESTINAL INFLAMMATION 3 0.0004
600 APLASTIC ANAEMIA 2 0.0004
601 HAEMATOCHEZIA 21 0.0004
602 ORAL CANDIDIASIS 5 0.0004
603 INCONTINENCE 4 0.0004
604 RENAL CYST 3 0.0004
605 BREAST PAIN 4 0.0004
606 FATIGUE 292 0.0004
607 ANAL FISTULA 2 0.0004
608 RHINITIS 3 0.0004
609 INTESTINAL OBSTRUCTION 14 0.0004
610 ANAL ABSCESS 2 0.0004
611 PRURITUS GENERALISED 8 0.0004
612 RENAL IMPAIRMENT 31 0.0004
613 UVEITIS 5 0.0004
614 SWELLING FACE 24 0.0004
615 ACUTE HEPATIC FAILURE 5 0.0004
616 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 26 0.0004
617 INTENTIONAL PRODUCT USE ISSUE 32 0.0004
618 SEIZURE 42 0.0004
619 VENTRICULAR TACHYCARDIA 6 0.0004
620 SPEECH DISORDER 19 0.0004
621 HEMIPLEGIA 3 0.0004
622 MENTAL STATUS CHANGES 10 0.0004
623 BLOOD UREA INCREASED 6 0.0004
624 OCULAR DISCOMFORT 4 0.0004
625 SKIN PLAQUE 3 0.0004
626 STATUS EPILEPTICUS 4 0.0004
627 HAEMORRHAGE 37 0.0004
628 PARALYSIS 5 0.0003
629 GASTRIC HAEMORRHAGE 4 0.0003
630 URINE OUTPUT DECREASED 3 0.0003
631 PANCREATITIS 18 0.0003
632 THROMBOCYTOPENIA 38 0.0003
633 PERIPHERAL SWELLING 52 0.0003
634 CELLULITIS 17 0.0003
635 BLOOD IRON DECREASED 4 0.0003
636 CARDIOTOXICITY 3 0.0003
637 COLON CANCER 5 0.0003
638 IMPAIRED HEALING 11 0.0003
639 CARDIO-RESPIRATORY ARREST 14 0.0003
640 GASTROINTESTINAL INFECTION 3 0.0003
641 MYOSITIS 3 0.0003
642 RESPIRATORY DISORDER 10 0.0003
643 ANAL INCONTINENCE 3 0.0003
644 BLOOD BILIRUBIN INCREASED 9 0.0003
645 APHASIA 10 0.0003
646 PELVIC PAIN 6 0.0003
647 BLOOD COUNT ABNORMAL 5 0.0003
648 PATHOGEN RESISTANCE 3 0.0003
649 SKIN IRRITATION 15 0.0003
650 LIVER INJURY 8 0.0003
651 DYSPHONIA 19 0.0003
652 HYPERCALCAEMIA 4 0.0003
653 OFF LABEL USE 283 0.0003
654 GENERALISED OEDEMA 4 0.0003
655 GASTROOESOPHAGEAL REFLUX DISEASE 26 0.0003
656 ADVERSE DRUG REACTION 29 0.0003
657 AMNESIA 21 0.0003
658 BLOOD ALKALINE PHOSPHATASE INCREASED 8 0.0003
659 ABDOMINAL DISCOMFORT 54 0.0003
660 BACTERIAL INFECTION 6 0.0003
661 NEPHROPATHY 3 0.0003
662 APPENDICITIS 3 0.0003
663 GASTRIC DISORDER 11 0.0003
664 LEUKOPENIA 16 0.0003
665 SECRETION DISCHARGE 4 0.0003
666 DYSARTHRIA 12 0.0003
667 MULTIPLE ORGAN DYSFUNCTION SYNDROME 9 0.0003
668 SPINAL DISORDER 3 0.0003
669 SPUTUM DISCOLOURED 3 0.0003
670 NEUTROPENIA 43 0.0003
671 HAEMATOTOXICITY 3 0.0003
672 HYPERSOMNIA 9 0.0003
673 HYPERKALAEMIA 11 0.0003
674 ABSCESS 5 0.0003
675 HERPES ZOSTER 18 0.0003
676 METABOLIC ACIDOSIS 10 0.0003
677 GLAUCOMA 6 0.0003
678 HIP FRACTURE 10 0.0003
679 MUSCLE SPASMS 57 0.0003
680 HIATUS HERNIA 4 0.0003
681 TOXICITY TO VARIOUS AGENTS 52 0.0003
682 HEPATIC ENZYME INCREASED 21 0.0003
683 ERYTHEMA 63 0.0003
684 ACUTE MYOCARDIAL INFARCTION 9 0.0003
685 THERAPY CHANGE 3 0.0003
686 URINARY INCONTINENCE 9 0.0003
687 C-REACTIVE PROTEIN INCREASED 11 0.0003
688 HYPOACUSIS 13 0.0003
689 APPETITE DISORDER 2 0.0003
690 ADVERSE REACTION 4 0.0003
691 FEBRILE NEUTROPENIA 20 0.0003
692 COGNITIVE DISORDER 14 0.0003
693 HYPOTENSION 60 0.0003
694 TOXIC SKIN ERUPTION 3 0.0003
695 ABDOMINAL DISTENSION 31 0.0003
696 FACE OEDEMA 5 0.0003
697 SUBARACHNOID HAEMORRHAGE 3 0.0003
698 TACHYPNOEA 4 0.0003
699 RASH ERYTHEMATOUS 14 0.0003
700 EAR DISCOMFORT 3 0.0003
701 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
702 PERIPHERAL COLDNESS 4 0.0003
703 FEMUR FRACTURE 9 0.0003
704 RESPIRATORY ARREST 8 0.0003
705 BONE PAIN 17 0.0003
706 INFECTION 42 0.0003
707 RESPIRATORY DISTRESS 8 0.0003
708 DIVERTICULITIS 8 0.0003
709 NERVOUS SYSTEM DISORDER 9 0.0003
710 OEDEMA PERIPHERAL 35 0.0003
711 WEIGHT FLUCTUATION 3 0.0003
712 LOCAL SWELLING 5 0.0003
713 ABDOMINAL PAIN UPPER 59 0.0003
714 DEMENTIA 8 0.0003
715 WOUND 8 0.0003
716 THROMBOSIS 23 0.0003
717 ENCEPHALOPATHY 7 0.0003
718 BLOOD TEST ABNORMAL 4 0.0003
719 SKIN DISCOLOURATION 13 0.0003
720 SEASONAL ALLERGY 4 0.0003
721 LIVER FUNCTION TEST INCREASED 6 0.0003
722 NIGHT SWEATS 9 0.0003
723 DEEP VEIN THROMBOSIS 18 0.0003
724 GASTROENTERITIS VIRAL 5 0.0003
725 LEUKOCYTOSIS 5 0.0003
726 CHEST PAIN 51 0.0003
727 BONE DISORDER 5 0.0003
728 FISTULA 3 0.0003
729 FRACTURE 5 0.0003
730 MUSCULAR WEAKNESS 30 0.0003
731 POLLAKIURIA 11 0.0003
732 VISION BLURRED 36 0.0003
733 BOWEL MOVEMENT IRREGULARITY 2 0.0003
734 SYNCOPE 26 0.0003
735 FREQUENT BOWEL MOVEMENTS 7 0.0003
736 LYMPHOMA 4 0.0003
737 ATRIOVENTRICULAR BLOCK 2 0.0003
738 MADAROSIS 3 0.0003
739 BACK PAIN 59 0.0003
740 PLATELET COUNT DECREASED 27 0.0003
741 ATAXIA 3 0.0003
742 SINUS DISORDER 5 0.0003
743 CEREBRAL HAEMORRHAGE 9 0.0003
744 UNEVALUABLE EVENT 19 0.0003
745 POLYNEUROPATHY 3 0.0003
746 HYPOTHYROIDISM 8 0.0003
747 MYELOSUPPRESSION 9 0.0002
748 NASOPHARYNGITIS 46 0.0002
749 MALAISE 109 0.0002
750 MUSCULOSKELETAL PAIN 13 0.0002
751 CONFUSIONAL STATE 40 0.0002
752 NOCTURIA 3 0.0002
753 ASPHYXIA 2 0.0002
754 PAIN IN EXTREMITY 72 0.0002
755 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
756 SMALL INTESTINAL OBSTRUCTION 3 0.0002
757 ESCHERICHIA INFECTION 2 0.0002
758 ACUTE CORONARY SYNDROME 2 0.0002
759 EOSINOPHIL COUNT INCREASED 2 0.0002
760 GASTROINTESTINAL HAEMORRHAGE 20 0.0002
761 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
762 FACIAL PARALYSIS 2 0.0002
763 WHITE BLOOD CELL COUNT INCREASED 9 0.0002
764 DIZZINESS 117 0.0002
765 RETCHING 5 0.0002
766 HAEMATURIA 8 0.0002
767 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0002
768 INFLUENZA 26 0.0002
769 MEMORY IMPAIRMENT 32 0.0002
770 ANURIA 2 0.0002
771 POOR QUALITY SLEEP 5 0.0002
772 OXYGEN SATURATION DECREASED 13 0.0002
773 DISEASE RECURRENCE 11 0.0002
774 VERTIGO 14 0.0002
775 ECZEMA 12 0.0002
776 NEUROTOXICITY 4 0.0002
777 IMMUNE SYSTEM DISORDER 3 0.0002
778 LIMB DISCOMFORT 7 0.0002
779 GOUT 4 0.0002
780 TOOTHACHE 4 0.0002
781 NEUROPATHY PERIPHERAL 21 0.0002
782 FALL 73 0.0002
783 TINNITUS 10 0.0002
784 ATRIAL FIBRILLATION 21 0.0002
785 FEELING COLD 6 0.0002
786 MASS 3 0.0002
787 HAEMOGLOBIN DECREASED 22 0.0002
788 STAPHYLOCOCCAL INFECTION 7 0.0002
789 HEPATOCELLULAR INJURY 3 0.0002
790 LOSS OF CONSCIOUSNESS 27 0.0002
791 VIRAL INFECTION 7 0.0002
792 EYE INFLAMMATION 2 0.0002
793 LETHARGY 12 0.0002
794 CHOLESTASIS 4 0.0002
795 DIABETIC KETOACIDOSIS 5 0.0002
796 PARAESTHESIA ORAL 3 0.0002
797 ERUCTATION 4 0.0002
798 KIDNEY INFECTION 4 0.0002
799 LABORATORY TEST ABNORMAL 6 0.0002
800 ABASIA 5 0.0002
801 DELIRIUM 7 0.0002
802 CATARACT 12 0.0002
803 IMMUNODEFICIENCY 3 0.0002
804 BLOOD PRESSURE ABNORMAL 4 0.0002
805 THERAPY NON-RESPONDER 9 0.0002
806 SPINAL FRACTURE 4 0.0002
807 ABDOMINAL PAIN LOWER 5 0.0002
808 GASTRIC CANCER 5 0.0002
809 BODY TEMPERATURE INCREASED 4 0.0002
810 HIP ARTHROPLASTY 3 0.0002
811 CHEST DISCOMFORT 20 0.0002
812 PHARYNGEAL OEDEMA 3 0.0002
813 CEREBROVASCULAR ACCIDENT 33 0.0002
814 UPPER RESPIRATORY TRACT INFECTION 9 0.0002
815 RIB FRACTURE 4 0.0002
816 ACUTE MYELOID LEUKAEMIA 3 0.0002
817 SWELLING 18 0.0002
818 HYPERGLYCAEMIA 7 0.0002
819 EYE IRRITATION 11 0.0002
820 PRODUCT USE COMPLAINT 3 0.0002
821 HEAD INJURY 6 0.0002
822 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
823 SCIATICA 3 0.0002
824 VISUAL IMPAIRMENT 23 0.0002
825 BURNING SENSATION 13 0.0002
826 BLOOD POTASSIUM INCREASED 3 0.0002
827 WHITE BLOOD CELL COUNT DECREASED 20 0.0002
828 ASPIRATION 2 0.0002
829 JOINT SWELLING 22 0.0002
830 PHOTOSENSITIVITY REACTION 3 0.0002
831 ILL-DEFINED DISORDER 11 0.0002
832 VISUAL ACUITY REDUCED 6 0.0002
833 SOMNOLENCE 36 0.0002
834 DRUG INEFFECTIVE 234 0.0002
835 ILLNESS 18 0.0002
836 CARDIAC DISORDER 16 0.0002
837 SURGERY 10 0.0002
838 DRUG INTERACTION 27 0.0002
839 WHEEZING 10 0.0002
840 BACTERAEMIA 2 0.0002
841 GAIT DISTURBANCE 32 0.0002
842 BLOOD PRESSURE FLUCTUATION 4 0.0002
843 BLOOD PRESSURE DECREASED 11 0.0002
844 MENTAL IMPAIRMENT 4 0.0002
845 BURSITIS 2 0.0002
846 ACCIDENTAL OVERDOSE 6 0.0002
847 CYTOPENIA 2 0.0002
848 RECTAL HAEMORRHAGE 7 0.0002
849 HEADACHE 102 0.0002
850 BLOOD GLUCOSE ABNORMAL 3 0.0002
851 HEART RATE INCREASED 16 0.0002
852 EYE SWELLING 6 0.0002
853 NECK PAIN 9 0.0002
854 THINKING ABNORMAL 3 0.0002
855 HYPERTENSION 34 0.0002
856 HYPOAESTHESIA 24 0.0002
857 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
858 DERMATITIS ALLERGIC 2 0.0002
859 FOOT FRACTURE 3 0.0002
860 INCREASED APPETITE 3 0.0002
861 THROAT IRRITATION 7 0.0002
862 SLEEP DISORDER 11 0.0002
863 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
864 RESPIRATORY TRACT INFECTION 4 0.0002
865 DEAFNESS 4 0.0002
866 BEDRIDDEN 2 0.0002
867 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
868 UPPER LIMB FRACTURE 3 0.0002
869 URINARY RETENTION 5 0.0001
870 CARDIAC FAILURE CONGESTIVE 12 0.0001
871 COVID-19 26 0.0001
872 BLINDNESS 6 0.0001
873 COMA 7 0.0001
874 CORONARY ARTERY OCCLUSION 2 0.0001
875 ANAPHYLACTIC REACTION 8 0.0001
876 HYPOGLYCAEMIA 7 0.0001
877 RHABDOMYOLYSIS 6 0.0001
878 PAIN 87 0.0001
879 MYALGIA 24 0.0001
880 SKIN BURNING SENSATION 10 0.0001
881 CARDIOGENIC SHOCK 2 0.0001
882 ANOSMIA 2 0.0001
883 DYSSTASIA 4 0.0001
884 NASAL CONGESTION 8 0.0001
885 CARDIOMYOPATHY 2 0.0001
886 TACHYCARDIA 12 0.0001
887 INSOMNIA 35 0.0001
888 ADVERSE EVENT 12 0.0001
889 EMOTIONAL DISORDER 4 0.0001
890 BASAL CELL CARCINOMA 2 0.0001
891 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
892 URTICARIA 21 0.0001
893 BLOOD GLUCOSE DECREASED 6 0.0001
894 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 6 0.0001
895 MOVEMENT DISORDER 4 0.0001
896 EXTRA DOSE ADMINISTERED 5 0.0001
897 OSTEONECROSIS 4 0.0001
898 PRODUCT USE IN UNAPPROVED INDICATION 30 0.0001
899 MYOCARDIAL INFARCTION 21 0.0001
900 CYTOMEGALOVIRUS INFECTION 2 0.0001
901 COAGULOPATHY 2 0.0001
902 HALLUCINATION 9 0.0001
903 FLUID RETENTION 6 0.0001
904 OSTEOARTHRITIS 5 0.0001
905 BLOOD PRESSURE INCREASED 18 0.0001
906 WEIGHT INCREASED 26 0.0001
907 HAEMATOMA 3 0.0001
908 VAGINAL HAEMORRHAGE 5 0.0001
909 DEPRESSION 26 0.0001
910 CONTUSION 11 0.0001
911 DEPRESSED MOOD 6 0.0001
912 DRUG EFFECT DECREASED 6 0.0001
913 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
914 NEPHROLITHIASIS 5 0.0001
915 MEDICATION ERROR 6 0.0001
916 PAIN IN JAW 3 0.0001
917 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
918 RED BLOOD CELL COUNT DECREASED 3 0.0001
919 FEELING ABNORMAL 25 0.0001
920 BALANCE DISORDER 9 0.0001
921 EAR PAIN 2 0.0001
922 CHOKING 2 0.0001
923 PALPITATIONS 12 0.0001
924 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
925 CHILLS 12 0.0001
926 HYPERSENSITIVITY 19 0.0001
927 CONDITION AGGRAVATED 31 0.0001
928 OESOPHAGEAL CARCINOMA 3 0.0001
929 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
930 ANXIETY 28 0.0001
931 DISCOMFORT 6 0.0001
932 SINUSITIS 10 0.0001
933 TREMOR 16 0.0001
934 RENAL FAILURE ACUTE 4 0.0001
935 DISTURBANCE IN ATTENTION 5 0.0001
936 CHRONIC KIDNEY DISEASE 7 0.0001
937 CHOLELITHIASIS 3 0.0001
938 TREATMENT NONCOMPLIANCE 5 0.0001
939 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
940 ARTHRITIS 7 0.0001
941 ARTHRALGIA 35 0.0001
942 THERAPEUTIC RESPONSE DECREASED 5 0.0001
943 RESTLESSNESS 3 0.0001
944 BRONCHITIS 6 0.0001
945 INTENTIONAL PRODUCT MISUSE 7 0.0001
946 CARDIOVASCULAR DISORDER 2 0.0001
947 HOSPITALISATION 12 0.0001
948 THERAPY CESSATION 4 0.0001
949 HYPERHIDROSIS 10 0.0001
950 ANAPHYLACTIC SHOCK 2 0.0001
951 BRADYCARDIA 4 0.0001
952 FEAR 2 0.0001
953 BLOOD GLUCOSE INCREASED 14 0.0001
954 OVERDOSE 16 0.0001
955 PRODUCT QUALITY ISSUE 10 0.0001
956 CARDIAC ARREST 6 0.0001
957 ROAD TRAFFIC ACCIDENT 3 0.0001
958 PARAESTHESIA 11 0.0001
959 ANGINA PECTORIS 2 0.0001
960 MENTAL DISORDER 3 0.0001
961 FLUSHING 7 0.0001
962 IRRITABILITY 4 0.0001
963 SUICIDE ATTEMPT 4 0.0001
964 DRUG ADMINISTRATION ERROR 2 0.0001
965 PRODUCT USE ISSUE 12 0.0001
966 RENAL CANCER 3 0.0001
967 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 12 0.0001
968 NERVOUSNESS 3 0.0001
969 CRYING 2 0.0001
970 HOT FLUSH 4 0.0001
971 DIABETES MELLITUS 4 0.0001
972 INFUSION RELATED REACTION 3 0.0000
973 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
974 INJURY 3 0.0000
975 ARRHYTHMIA 2 0.0000
976 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
977 MIGRAINE 4 0.0000
978 MOBILITY DECREASED 3 0.0000
979 AGITATION 3 0.0000
980 AGGRESSION 2 0.0000
981 INCORRECT DOSE ADMINISTERED 9 0.0000
982 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
983 ARTHROPATHY 2 0.0000
984 ASTHMA 4 0.0000
985 SUICIDAL IDEATION 3 0.0000
986 FEELING HOT 2 0.0000
987 BREAST CANCER 3 0.0000
988 PSORIASIS 4 0.0000
989 DRUG DOSE OMISSION 5 0.0000
990 COMPLETED SUICIDE 2 0.0000
991 NO ADVERSE EVENT 3 0.0000
992 PRODUCT DOSE OMISSION ISSUE 3 0.0000